MC

457.1

-2.14%↓

SANES

10.386

+1.21%↑

SAF

273.2

+0.4%↑

BBVA

18.82

+0.83%↑

BNP

91.41

+1.75%↑

MC

457.1

-2.14%↓

SANES

10.386

+1.21%↑

SAF

273.2

+0.4%↑

BBVA

18.82

+0.83%↑

BNP

91.41

+1.75%↑

MC

457.1

-2.14%↓

SANES

10.386

+1.21%↑

SAF

273.2

+0.4%↑

BBVA

18.82

+0.83%↑

BNP

91.41

+1.75%↑

MC

457.1

-2.14%↓

SANES

10.386

+1.21%↑

SAF

273.2

+0.4%↑

BBVA

18.82

+0.83%↑

BNP

91.41

+1.75%↑

MC

457.1

-2.14%↓

SANES

10.386

+1.21%↑

SAF

273.2

+0.4%↑

BBVA

18.82

+0.83%↑

BNP

91.41

+1.75%↑

Search

Gimv NV

Closed

SectorFinance

47.85 0.21

Overview

Share price change

24h

Current

Min

47.5

Max

48.3

Key metrics

By Trading Economics

Income

127M

Sales

65M

P/E

Sector Avg

8.282

39.62

EPS

3.4

Dividend yield

5.27

Profit margin

195.239

Employees

94

EBITDA

128M

Dividends

By Dow Jones

Dividend yield

Sector Avg

5.27%

4.52%

Next Earnings

21 maj 2026

Market Stats

By TradingEconomics

Market Cap

1.8B

Previous open

47.64

Previous close

47.85

News Sentiment

By Acuity

82%

18%

415 / 439 Ranking in Finance

Gimv NV Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

27 kwi 2026, 23:15 UTC

Major News Events

U.K. Consumers Pay Less But Full Impact of Mideast War to Be Seen

27 kwi 2026, 23:08 UTC

Earnings
Major Market Movers

LendingClub Shares Gain on 1Q Profit, Revenue Beat

27 kwi 2026, 23:58 UTC

Earnings

Samsung SDI 1Q Net Profit Beat FactSet-Compiled Consensus

27 kwi 2026, 23:58 UTC

Earnings

Samsung SDI 1Q Net KRW56.10B Vs. Loss KRW216.00B >006400.SE

27 kwi 2026, 23:56 UTC

Earnings

Samsung SDI 1Q Oper Loss KRW155.60B Vs. Loss KRW434.10B >006400.SE

27 kwi 2026, 23:56 UTC

Earnings

Samsung SDI 1Q Rev KRW3.576T Vs. KRW3.177T >006400.SE

27 kwi 2026, 23:48 UTC

Market Talk

Nikkei May Remain Rangebound Amid Uncertainty Over Iran Conflict -- Market Talk

27 kwi 2026, 23:42 UTC

Market Talk

Australian Consumer Confidence Making a Slow Come Back -- Market Talk

27 kwi 2026, 23:34 UTC

Market Talk
Major News Events

Gold Edges Higher as Investors Assess Iran's Proposal to U.S. -- Market Talk

27 kwi 2026, 23:30 UTC

Market Talk

Australia's NDIS Could Lose 'Social Licence' If Not Reined In -- Market Talk

27 kwi 2026, 23:08 UTC

Market Talk

Polymetals's Revenue Outlook 'Extraordinary' for a Small-Cap Stock -- Market Talk

27 kwi 2026, 23:02 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

27 kwi 2026, 23:02 UTC

Market Talk

Warsh Will Probably Lean a Bit More Dovish Than Powell -- Market Talk

27 kwi 2026, 22:42 UTC

Market Talk

BOJ Expected to Keep Rates On Hold; Guidance to Skew Hawkish -- Market Talk

27 kwi 2026, 22:10 UTC

Earnings

Haier Smart Home: Results Also Weighed by Weak Demand in China-U.S. Markets >600690.SH

27 kwi 2026, 22:09 UTC

Earnings

Haier Smart Home: Increase in Tariff Costs, Extreme Weather Conditions Hurt Results >600690.SH

27 kwi 2026, 22:09 UTC

Earnings

Haier Smart Home 1Q Net CNY4.65B Vs. Net CNY5.49B >600690.SH

27 kwi 2026, 22:09 UTC

Earnings

Haier Smart Home 1Q Rev CNY73.69B Vs. CNY79.12B >600690.SH

27 kwi 2026, 21:56 UTC

Earnings

Tsingtao Brewery: Cost Controls Among Factors Supporting Results >0168.HK

27 kwi 2026, 21:55 UTC

Earnings

Tsingtao Brewery 1Q Net CNY1.80B Vs. Net CNY1.71B >0168.HK

27 kwi 2026, 21:55 UTC

Earnings

Tsingtao Brewery 1Q Rev CNY10.29B Vs. CNY10.45B >0168.HK

27 kwi 2026, 21:44 UTC

Earnings

Tianqi Lithium: Higher Demand for Products From EV Sector Also Boosted Financial Performance >002466.SZ

27 kwi 2026, 21:43 UTC

Earnings

Tianqi Lithium: Increase in Average Selling Prices of Major Lithium Products Supported Results >002466.SZ

27 kwi 2026, 21:41 UTC

Earnings

Tianqi Lithium 1Q Rev CNY5.13B Vs. CNY2.58B >002466.SZ

27 kwi 2026, 21:41 UTC

Earnings

Tianqi Lithium 1Q Net CNY1.88B Vs. Net CNY104.27M >002466.SZ

27 kwi 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

27 kwi 2026, 20:50 UTC

Market Talk
Major News Events

Basic Materials Roundup: Market Talk

27 kwi 2026, 20:50 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Financial Services Roundup: Market Talk

27 kwi 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

27 kwi 2026, 20:39 UTC

Earnings

Nucor: Operating Segments Earnings Growth Driven by Trade Policies That Continue to Reduce Flood of Unfairly Traded Imports Into U.S. >NUE

Peer Comparison

Price change

Gimv NV Forecast

Rating Consensus

By TipRanks

0 ratings

0

Buy

0

Hold

0

Sell

Sentiment

By Acuity

415 / 439 Ranking in Finance

News Sentiment

Very Strong Bearish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Gimv NV

Gimv NV is a private equity and venture capital firm specializing in direct and fund of funds investments. For direct investments, the firm specializes in buyouts, growth capital, middle market, debt, shareholder loans, seed, startups, early to mid-stage, late venture, public to private transactions, small and medium sized enterprises, later stage, mature, replacement capital, bridge financing, and recapitalization. Within fund of funds, it seeks to invest in venture capital and private equity funds. It seeks to invest in high performance growth companies that respond to that can speed up their internal growth through acquisitions. The firm typically invests in consumer, connected consumer, fintech; health and care; smart industries; and sustainable cities. Within consumer, it seeks to provide growth capital to emerging leaders. Within health and care platform, the firm seeks to invest in companies that can grow either organically or through a buy and build strategy. Within consumer, it focuses on consumer goods, food and beverage, healthy food, sport, convenience food, personal luxury, career, home & deco, baby & kids, pet products, retail, consumer services, media and content, travel and leisure, education, digital economy and online sectors. Within health and care sector, it focuses on life sciences, medtech, and health and care services. The firm focuses on biotech/biopharma comprising drugs, platform technologies, vaccines and diagnostic tests, preclinical, early clinical, and late clinical, medtech such as medical devices, consumables, IT and small equipment, and health and care services-based companies. It also seeks to be an active shareholder, preferably lead or co-lead in its investments. Within smart industries, it focuses on equipment, services and tools for resource efficient development and production, automotive and aerospace, both optimizing of the existing and development of new means of transport, software and services harnessing the flexibility of the cloud, smart data management and advanced c
help-icon Live chat